We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Genzyme Faces Suit Over ‘Arbitrary’ Dose Reduction of Shorted Fabry Drug
Genzyme Faces Suit Over ‘Arbitrary’ Dose Reduction of Shorted Fabry Drug
April 2, 2012
The widow of an Idaho Fabry disease patient who died during a shortage of Genzyme’s Fabrazyme is suing the drugmaker, claiming it arbitrarily rationed the drug in favor of young patients and failed to adequately warn about the dangers of taking the drug at reduced doses.